Literature DB >> 10666653

Surgical treatment of metastatic disease of the femur.

K C Swanson1, D J Pritchard, F H Sim.   

Abstract

Nearly every malignant neoplasm has been described as having the capability to metastasize to bone. Of the estimated 1.2 million new cases of cancer diagnosed annually, more than 50% will eventually demonstrate skeletal metastasis. Advances in systemic and radiation therapy have led to a considerable improvement in the prognosis of patients with metastatic disease. As a result, orthopaedic surgeons are being asked with increasing frequency to evaluate and treat the manifestations of skeletal metastases. The femur is commonly the site of large impending lesions and complete pathologic fractures. Although the health status of some patients may preclude operative intervention, established pathologic fractures of the femur and metastatic lesions deemed likely to progress to imminent fracture generally should be treated surgically. A rational approach to selection of the proper treatment for these problems includes consideration of the patient's overall medical condition and the type, location, size, and extent of the tumor. Treatment principles are the same regardless of location. A construct should ideally provide enough stability to allow immediate full weight bearing with enough durability to last the patient's expected lifetime. All areas of weakened bone should be addressed at the time of surgery in anticipation of disease progression. To minimize disease progression and possible implant or internal fixation failure, postoperative external-beam irradiation should be considered.

Entities:  

Mesh:

Year:  2000        PMID: 10666653     DOI: 10.5435/00124635-200001000-00006

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  23 in total

1.  Case series of patients with pathological dyaphiseal fractures from metastatic bone disease.

Authors:  Dinu Vermesan; Radu Prejbeanu; Horia Haragus; Alis Dema; Manuel D Oprea; Diana Andrei; Dan V Poenaru; Marius Niculescu
Journal:  Int Orthop       Date:  2017-08-02       Impact factor: 3.075

2.  What Are the Functional Results and Complications With Long Stem Hemiarthroplasty in Patients With Metastases to the Proximal Femur?

Authors:  Joel R Peterson; Alexander P Decilveo; Ian T O'Connor; Ivan Golub; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

3.  What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?

Authors:  Ryan P McLynn; Nathaniel T Ondeck; Jonathan N Grauer; Dieter M Lindskog
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

4.  [Subtrochanteric renal cell carcinoma metastasis: implantation of a femoral head preserving prosthesis].

Authors:  A S Spiro; L Grossterlinden; J Zustin; J M Rueger; M H Priemel
Journal:  Orthopade       Date:  2011-03       Impact factor: 1.087

5.  Outcomes of knee arthroplasty for primary treatment of pathologic peri-articular fractures of the distal femur and proximal tibia.

Authors:  Joshua D Johnson; Cody C Wyles; Kevin I Perry; Brandon J Yuan; Peter S Rose; Matthew T Houdek
Journal:  Int Orthop       Date:  2019-09-04       Impact factor: 3.075

6.  Intramedullary nailing of femoral diaphyseal metastases: is it necessary to protect the femoral neck?

Authors:  Bryan Moon; Patrick Lin; Robert Satcher; Justin Bird; Valerae Lewis
Journal:  Clin Orthop Relat Res       Date:  2014-11-26       Impact factor: 4.176

7.  Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members.

Authors:  Matthew Steensma; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2012-12-18       Impact factor: 4.176

8.  Reinforced cementoplasty using dedicated spindles in the management of unstable malignant lesions of the cervicotrochanteric region.

Authors:  Kévin Premat; Frédéric Clarençon; Raphael Bonaccorsi; Vincent Degos; Évelyne Cormier; Jacques Chiras
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

9.  Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone?

Authors:  Hasham M Alvi; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-10-27       Impact factor: 4.176

10.  Is a Cephalomedullary Nail Durable Treatment for Patients With Metastatic Peritrochanteric Disease?

Authors:  David H Chafey; Valerae O Lewis; Robert L Satcher; Bryan S Moon; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.